(NASDAQ: ALEC) Alector's forecast annual revenue growth rate of -18.74% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 100.47%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.34%.
Alector's revenue in 2025 is $69,048,000.On average, 11 Wall Street analysts forecast ALEC's revenue for 2025 to be $1,865,180,354, with the lowest ALEC revenue forecast at $1,235,267,209, and the highest ALEC revenue forecast at $2,097,345,534. On average, 11 Wall Street analysts forecast ALEC's revenue for 2026 to be $4,861,824,866, with the lowest ALEC revenue forecast at $450,795,579, and the highest ALEC revenue forecast at $22,039,865,226.
In 2027, ALEC is forecast to generate $2,995,007,240 in revenue, with the lowest revenue forecast at $1,283,621,311 and the highest revenue forecast at $5,008,851,899.